LINC-ROR and cancer: As a ROR ligand, melatonin not only mitigates oxidative damage by neutralizing ROS and by enhancing antioxidant defenses, but also promotes ROR-mediated mechanisms that induce apoptosis in cancer cells [72,73,74,75,76,77,78].